Lilly Asia Ventures
Finance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2730 Sand Hill Rd Ste 130, Menlo Park, C...Phone Number
(650) 561-3411Website
www.lillyasiaventures.comRevenue
$6.4 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
2
2
2
2
2
About Lilly Asia Ventures
Lilly Asia Ventures ("LAV") is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto, California. Its vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.Explore more
Lilly Asia Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lilly Asia Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Lilly Asia Ventures
Product Launch: Get notified when Lilly Asia Ventures launches new products
Earning: See what the market has to say on Lilly Asia Ventures recently announced quarterly report
Click to see if Lilly Asia Ventures had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Lilly Asia Ventures has new funding data
Website visits: Recent activity has been detected on your website
Lilly Asia Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Lilly Asia Ventures is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Lilly Asia Ventures has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Lilly Asia Ventures as Masked Content
Find more new buyers
Compare Similar Companies to Lilly Asia Ventures
Compare insights from companies similar to Lilly Asia Ventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lilly Asia Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Lilly Asia Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Lilly Asia Ventures.
Lilly Asia Ventures Tech Stack
A closer look at the technologies used by Lilly Asia Ventures
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Lilly Asia Ventures News & Media
Pulnovo Medical Closes $100M Series C
Pulnovo Medical, a Shanghai, China-based medtech company developing devices for pulmonary hypertension (PH) and heart failure (HF), raised $100M in Series C funding. The round was led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capita. The company intends to use the funds to advance its global […] The post Pulnovo Medical Closes $100M Series C appeared first on FinSMEs.Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB
HANGZHOU, China, Sept. 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, today announced the successful completion of Series C2 financing. This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperity Investment, Haibang Venture and Howbuy Primary Fund, while original shareholders, New Alliance Capital andRonovo Surgical Emerges with $50M+ in Funding
Ronovo Surgical, a Shanghai, China-based robotic and digital surgery space company, raised $50M+ in funding. The round was led by LongRiver Investments, with participation from Lilly Asia Ventures, Vivo Capital, Matrix Partners China, and GGV Capital. The company intends to use the funds to accelerate the multi-discipline clinical trial for Carina, strengthen R&D and clinical […] The post Ronovo Surgical Emerges with $50M+ in Funding appeared first on FinSMEs.ADARx Pharmaceuticals Raises $46M in Series B-1 Financing
ADARx Pharmaceuticals, a San Diego, CA-based clinical stage biotechnology company developing RNA-targeting therapeutics, raised $46M in Series B-1 funding. The round was led by Ascenta Capital with participation from OrbiMed Advisors, SR One Capital Management, Lilly Asia Ventures, and Sirona Capital. In conjunction with this financing, Dr. Lorence Kim of Ascenta Capital has joined the […] The post ADARx Pharmaceuticals Raises $46M in Series B-1 Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lilly Asia Ventures
Sign Up For FreeTo access detailed company insights
Lilly Asia Ventures ("LAV") is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto, California. Its vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.... Read More
